19 January 2018 - Deborah Wilkes
Archived
Stada Arzneimittel has regained rights to its Hedrin head-lice remedy in Belgium, Portugal and Spain, following the early termination of a licensing agreement with Sanofi.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.